30 completed, 5 recruiting, 2 active not recruiting, 2 not yet recruiting. 32 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 32 | Completed 23, Recruiting 3, Active not recruiting 2, Unknown 2, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Hearing Loss, Mixed Conductive-Sensorineural: new trials by email Literature Review of Hearing Loss, Mixed Conductive-Sensorineural trials Research Report on Hearing Loss, Mixed Conductive-Sensorineural
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-market Evaluation of the Transition From the Baha Connect System to the Osia System in Adult Bone Conduction Implant Recipients Cochlear™ Osia® System, Cochlear™ Baha® System - Bone Conduction, Hearing Loss, Conductive | Not applicable | Recruiting | Cochlear | 20 | 2026-07-24 | 2026-09-02 |
| Comparative Study of Non-surgical Hearing Devices Based on Bone Conduction Bone conduction devices - Mixed Hearing Loss, Conductive Hearing Loss | Not applicable | Not yet recruiting | Oticon Medical | 20 | 2026-06-01 | 2026-05-12 |
| Evaluation of Actual Maximum Gain in Bone Anchored Devices Bone Anchored Device A, Bone Anchored Device B, Bone Anchored Device C - Mixed Hearing Loss | Not applicable | Recruiting | Oticon Medical | 20 | 2025-12-04 | 2025-12-19 |
| Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients Cochlear™ Osia® System (Osia® 2), Cochlear™ Osia® System (Osia® 3) - Hearing Loss, Mixed, Hearing Loss, Conductive | Not applicable | Completed | Cochlear | 29 | 2025-09-09 | 2026-01-08 |
| Sentio Systematic Evaluation Transcutaneous bone conduction hearing system - Hearing Loss, Bilateral or Unilateral, Hearing Loss, Conductive | Not yet recruiting | Oticon Medical | 100 | 2025-09-01 | 2025-09-08 | |
| A Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and Efficacy Spectacle Hearing Aid - Hearing Loss Mixed | Phase 2 / Phase 3 | Recruiting | Nuance Hearing | 89 | 2025-07-27 | 2025-12-15 |
| Pediatric Expansion Study of the Sentio System Active transcutaneous bone conduction system - Hearing Loss, Conductive, Hearing Loss, Mixed | Not applicable | Active not recruiting | Oticon Medical | 50 | 2025-04-30 | 2026-08-14 |
| Evaluating the Safety of BONEBRIDGE Implants in Children Under Five Years Old: This Study Looks at Children Under Five Who Got BONEBRIDGE BCI 602 Implants. It Collects Information on Any Problems With the Device or the Surgery to See if it is Safe Within the First Year After the Operation. Bone Conduction Implant (BCI) - Hearing Loss, Conductive, Hearing Loss, Mixed | Completed | MED-EL Elektromedizinische Geräte GesmbH | 9 | 2024-09-25 | 2026-04-01 | |
| Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users Cochlear Osia 3 Sound Processor, Cochlear™ Osia® 2 Sound Processor - Hearing Loss, Mixed Conductive-Sensorineural, Hearing Loss, Conductive | Not applicable | Completed | Cochlear | 12 | 2024-07-04 | 2026-01-21 |
| Expanded Indications in the Pediatric BONEBRIDGE Population MED-EL BONEBRIDGE Bone Conduction Implant - Hearing Loss, Conductive, Hearing Loss, Mixed | Not applicable | Active not recruiting | Med-El Corporation | 36 | 2023-10-03 | 2026-08-19 |
| Preschool Hearing Screening Otoacoustic Emissions Testing, Pure Tone Audiometry - Hearing Loss, Hearing Disorders in Children | Not applicable | Recruiting | University of California, San Francisco | 13764 | 2023-10-01 | 2026-02-02 |
| Subjective and Audiological Benefit of BONEBRIDGE (BCI602) With Two Different Fitting Strategies Fitting of the audioprocessor with the auditory implant BCI602 - Bone Conduction Deafness, Quality of Life | Not applicable | Unknown | Hospital Universitario La Paz | 1 | 2023-06-27 | 2023-09-15 |
| Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear Sentio 1 - Conductive Hearing Loss, Mixed Hearing Loss | Not applicable | Completed | Oticon Medical | 11 | 2022-11-15 | 2025-12-03 |
| Osia 2 Pediatric Expansion Study Osia 2 System - Mixed Hearing Loss, Single-Sided Deafness | Not applicable | Completed | Cochlear | 50 | 2022-01-26 | 2024-12-11 |
| Clinical Investigation Study of Safety and Performance of the Sentio System. Active transcutaneous bone conduction hearing system - Hearing Loss, Conductive, Hearing Loss, Mixed | Not applicable | Unknown | Oticon Medical | 51 | 2022-01-19 | 2024-04-03 |
| Investigation of an Updated Bone-anchored Sound Processor Device A, Device B - Hearing Loss, Hearing Loss, Conductive | Not applicable | Completed | Oticon Medical | 15 | 2021-09-30 | 2022-04-20 |
| Long Term Clinical Investigation to Evaluate Clinical Performance, Safety and Patient Reported Outcomes of an Active Osseointegrated Steady-State Implant System Active Osseointegrated Steady-State Implant System (OSI) - Hearing Loss | Not applicable | Completed | Cochlear | 20 | 2021-05-06 | 2024-06-10 |
| Investigating Hearing With Ponto 3 SuperPower, a Bone Anchored Hearing Aid - Investigating Hear Collection of Pure tone thresholds from audiogram measured prior to fitting of Ponto 3 SuperPower, Collection of BC In-situ thresholds from BC In-situ audiogram measured during fitting of Ponto 3 SuperPower, Collection of Aided sound field thresholds measured with the Ponto 3 SuperPower - Hearing Loss, Conductive, Hearing Loss Mixed | Completed | Oticon Medical | 57 | 2021-03-16 | 2025-08-26 | |
| Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID) No intervention - Hearing Loss, Conductive, Hearing Loss, Mixed | Recruiting | University of South Florida | 50 | 2021-01-29 | 2026-09-09 | |
| Investigating Hearing With the Ponto 4, a Bone Anchored Hearing Aid Audiometry - Hearing Loss, Conductive, Hearing Loss, Mixed | Not applicable | Completed | Oticon Medical | 20 | 2021-01-15 | 2025-07-31 |
Showing 20 of 43. Sign in to see all of them.
Hearing Loss, Conductive (35) · Hearing Loss (13) · Hearing Loss, Unilateral (8) · Deafness (7) · Hearing Loss, Sensorineural (4) · Ear Diseases (3) · Hearing Disorders (2) · Hearing Loss, Bilateral (2) · Cholesteatoma (1) · Hearing Loss, Noise-Induced (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Otitis Media with Effusion (1) · Otorhinolaryngologic Diseases (1)
Pathological Conditions, Signs and Symptoms (43) · Signs and Symptoms (43) · Nervous System Diseases (42) · Neurologic Manifestations (42) · Otorhinolaryngologic Diseases (42) · Sensation Disorders (42) · Hearing Disorders (41) · Ear Diseases (40) · Hearing Loss (30) · Behavior (1) · Health Behavior (1) · Keratosis (1) · Otitis (1) · Otitis Media (1) · Skin Diseases (1)
Audiometry (1) · Bone Conduction (1) · Evoked Potentials, Auditory (1) · Hearing (1) · Minimally Invasive Surgical Procedures (1) · Patient Reported Outcome Measures (1) · Surgical Procedures, Operative (1)
Oticon Medical (16) · Cochlear (11) · MED-EL Elektromedizinische Geräte GesmbH (3) · Med-El Corporation (3) · Cochlear Bone Anchored Solutions (2) · Hospital Universitario La Paz (1) · Medtronic Surgical Technologies (1) · Nuance Hearing (1) · Universitaire Ziekenhuizen KU Leuven (1) · University Hospital, Ghent (1) · University of California, San Francisco (1) · University of South Florida (1) · VA Office of Research and Development (1)
United States (12) · Netherlands (8) · Sweden (7) · Australia (6) · United Kingdom (6) · Denmark (4) · Germany (4) · Spain (4) · Belgium (3) · France (2) · Hong Kong (2) · Austria (1) · Canada (1) · Israel (1) · Poland (1)
Myrthe Hol, MD, PhD (3) · Robert Stokroos, Professor (2) · Ann-Charlotte Persson (1) · Assen Koitschev, Prof. Dr. (1) · Chris L Jacobsen, MD (1) · Craig Buchman, MD (1) · David Foyt, MD (1) · Douglas Chen, MD (1) · Dylan K Chan, MD, PhD (1) · Emmanuel AM Mylanus, MD, PhD (1) · Emmanuel Mylanus, MD, PhD (1)
PMID 37552281, PMID 27829464, PMID 32231633, PMID 33716934, PMID 35878640, PMID 36625869, PMID 37400140, PMID 38552429, PMID 40214186, PMID 41250191